Tetrous
Biologic solutions to optimize enthesis reformation, EnFix® is the future of bone to tendon healing.
$6.5M Series A ·
Source: startupintros.com
Funding history ↓Signals
Website registeredOct 3, 2018 (8 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $6.5M | — | startupintros.com |
Timeline
- Website created
Founders and team
- BEBradley E. Patt Co-founder, CEO, and Chairman of the Boardsource: tetrous.com
AJ
Andrew J. Carter FounderTB
Thurman Ballard Vice President of Sales
Similar Health and bio companies
PProgenerative MedicalVVumedi$140M Series B+ · Nov 2026
NNeurosterix$105M Series B+ · Nov 2026
OOSMUNDA$14.99M Series B+ · Nov 2026
BBoston Medical Sciences$34.69M Series B+ · Nov 2026
AAraceli Biosciences$4.5M Seed · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tetrous (get a free API key).